DeepMed Research

Ente Ospedaliero Ospedali Galliera

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Established: 1888-01-01

Employees: 1K

Market Cap: -

Website: http://www.galliera.it

Clinical Trials

Long-term Follow-up of the TAM-01 Study

Not yet recruiting

Conditions: Breast Cancer Invasive

Interventions: Drug: Tamoxifen (Nolvadex)
Drug: Tamoxifen (Nolvadex) placebo

First Posted Date: 2025-05-21

Last Posted Date: 2025-05-25

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 500

Registration Number: NCT06982313

Locations: 🇮🇹
E. O. Ospedali Galliera, Genoa, Italy

Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.

Phase 2

Completed

Conditions: Prostate Cancer
Prostatic Intraepithelial Neoplasia

Interventions: Drug: Flutamide
Drug: Finasteride
Other: Placebo

First Posted Date: 2024-09-19

Last Posted Date: 2024-09-19

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 125

Registration Number: NCT06601205

Locations: 🇮🇹
Medical Oncology Ente Ospedaliero Ospedali Galliera, Genova, Italy

Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

Phase 3

Recruiting

Conditions: Carcinoma, Ovarian Epithelial
Low Grade Serous Adenocarcinoma of Ovary

Interventions: Drug: Letrozole tablets
Drug: carboplatin AUC 5 and paclitaxel 175 mg/m2

First Posted Date: 2022-11-01

Last Posted Date: 2025-01-27

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 132

Registration Number: NCT05601700

Locations: 🇮🇹
Ospedale San Donato, Arezzo, AR, Italy
🇮🇹
Ospedale degli Infermi, Ponderano, BI, Italy
🇮🇹
Ospedale San Martino, Belluno, BL, Italy

and more 15 locations

Effect of Gender on Distress and Fatigue in Cancer Patients

Recruiting

Conditions: Cancer

Interventions: Other: Psychological session

First Posted Date: 2021-11-16

Last Posted Date: 2023-10-24

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 500

Registration Number: NCT05122052

Locations: 🇮🇹
E.O. Ospedali Galliera, Genova, Italy

BNT162b2 Messenger Ribonucleic Acid (mRNA) Covid-19 Vaccine in Cancer Patients on Active Treatment

Conditions: Neoplasms
Cancer, Treatment-Related

Interventions: Biological: BNT162b2 mRNA Covid-19 Vaccine

First Posted Date: 2021-06-21

Last Posted Date: 2021-06-21

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 300

Registration Number: NCT04932863

Locations: 🇮🇹
E.O. Ospedali Galliera, Genova, Italy

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Phase 3

Terminated

Conditions: Ovarian Cancer

Interventions: Drug: Exemestane
Other: Placebo oral tablet

First Posted Date: 2020-07-08

Last Posted Date: 2024-02-12

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 23

Registration Number: NCT04460807

Locations: 🇮🇹
ASST degli Spedali Civili di Brescia, Brescia, BS, Italy
🇮🇹
Azienda Ospedaliera per l'emergenza Cannizzaro, Catania, CT, Italy
🇮🇹
UOS Oncologia Ginecologica, Ospedale S. Gerardo, Monza, MB, Italy

and more 44 locations

Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)

Conditions: Liver Fibrosis

First Posted Date: 2017-09-26

Last Posted Date: 2017-09-26

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 100

Registration Number: NCT03293953

Locations: 🇮🇹
SC Radiodiagnostica, Genova, Italy

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients

Phase 2

Terminated

Conditions: Tertiary Prevention in Colon Cancer

Interventions: Other: Placebo
Drug: MET
Drug: ASA

First Posted Date: 2017-02-09

Last Posted Date: 2025-01-27

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 160

Registration Number: NCT03047837

Locations: 🇮🇹
Medical Oncology Ente Ospedaliero Ospedali Galliera, Genova, Italy

Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma

Not Applicable

Completed

Conditions: Colorectal Adenoma
Risk Reduction

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Mirtoselect® + Meriva®

First Posted Date: 2013-09-23

Last Posted Date: 2024-11-21

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 45

Registration Number: NCT01948661

Locations: 🇮🇹
"Gastroenterologia d'urgenza ed Endoscopia digestiva" Ospedale di Lavagna ASL 4 Chiavarese, Chiavari, Italy
🇮🇹
S.S. Gastroenterologia Ospedale Villa Scassi, ASL3 Genovese, Genoa, Italy
🇮🇹
Divisione di Prevenzione e Genetica Oncologica, IEO, Milan, Italy

and more 1 locations

Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia

Completed

Conditions: Pulmonary Arterial Hypertension
Thalassemia Intermedia
Thalassemia Major

Interventions: Other: Physician standard-of-care according to ESC/ERS Guidelines

First Posted Date: 2011-12-22

Last Posted Date: 2022-08-04

Lead Sponsor: Ente Ospedaliero Ospedali Galliera

Target Recruit Count: 1500

Registration Number: NCT01496963

Locations: 🇮🇹
Clinica pediatrica Ospedale Microcitemico, Cagliari, Italy
🇮🇹
SCDU Microcitemie-Pediatria A.O. Universitaria S.Luigi Gonzaga di Orbassano, Orbassano, Turin, Italy
🇮🇹
DH Microcitemia dell'adulto Ospedale Microcitemico, Cagliari, Italy

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy